Epidemiology and surveillance implications of community-acquired pneumonia in children

Eui Jeong Roh1, Jung Yeon Shim2, Eun Hee Chung3

  • 1Department of Pediatrics, Chungnam National University Hospital, Daejeon, Korea.

Insights

Community-acquired pneumonia (CAP) remains a major global health threat in children. Continuous surveillance of respiratory pathogens, including emerging viruses like SARS-CoV-2, is crucial for effective treatment and vaccine development.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Community-acquired pneumonia (CAP) is a leading cause of childhood hospitalization and mortality globally.
  • While immunizations have reduced bacterial pneumonia, respiratory viruses, including SARS-CoV-2, remain significant pathogens.
  • Emerging infectious agents necessitate ongoing investigation into CAP epidemiology and causative agents.

Purpose of the Study:

  • To investigate the epidemiology of CAP in children.
  • To identify causative pathogens, including Streptococcus pneumoniae serotypes and Mycoplasma pneumoniae mutations.
  • To inform antibiotic use and guide future vaccine development through pathogen surveillance.

Main Methods:

  • A study by the Pneumonia and Respiratory Disease Study Group in Korea investigated CAP pathogens in hospitalized children.
  • Analysis included Streptococcus pneumoniae serotyping and Mycoplasma pneumoniae gene mutation prevalence.
  • Antibiotic resistance patterns and serotype data were assessed.

Main Results:

  • Data on causative pathogens, Streptococcus pneumoniae serotypes, and Mycoplasma pneumoniae prevalence were gathered.
  • Antibiotic resistance and serotype information were obtained to guide empirical antibiotic treatment.
  • Findings contribute to understanding pathogen changes and prevalence for vaccine development.

Conclusions:

  • Continuous national surveillance of respiratory pathogens is essential for monitoring CAP epidemiology.
  • Surveillance aids in managing antibiotic resistance and developing effective vaccines.
  • Monitoring helps track emerging infectious diseases like SARS-CoV-2.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
302
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
365
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
169
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
429
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
427